Vaccine adjuvant comprising interleukin-15
US5747024A · kind A · utility
37Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1995 |
| Grant date | May 5, 1998 |
| Priority date | — |
| Expiry date | Jul 19, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55527
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of enhancing a mammal's immune response to a vaccine antigen are disclosed. Interleukin-15 can be used as a vaccine adjuvant to enhance or potentiate the immune response to a vaccine. Compositions comprising an immunogenic amount of vaccine antigen and an immunogenicity-augmenting amount of IL-15 are also provided by the invention. IL-15 can be used alone in the invention or in concurrent or sequential combination with additional vaccine adjuvants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.